CHINARES PHARMA introduces new product system for downstream customers under 1,4-Butanediamine

China Resources Pharmaceutical (03320.HK) announced that its business unit China Resources Double-Crane, under the group, has achieved an important breakthrough in the field of synthetic biology industrial application. The core bio-based product 1,4-butanediamine has been successfully introduced into the newly launched Wouper PA46 bio-based high-performance polyamide material system by downstream partner WOTE, marking the official entry of the group's related products into the high-performance materials end application field.

WOTE's Wouper PA46 is positioned as a benchmark product for bio-based high-performance polyamides. This material combines the green attributes of bio-based raw materials with the stringent requirements of high-performance engineering plastics, featuring high strength, low creep, fatigue resistance, wide temperature range wear resistance, self-lubrication, high fluidity, weld resistance, oil resistance, and hydrolysis resistance, making it widely applicable in high-end manufacturing fields such as automotive transmission systems and precision electronics and electrical industries, demonstrating strong downstream application potential